This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Rare Disease Conference 2026 - Rare Disease Summit
March 17-19, 2026
Pre-Conference Workshops on March 16, 2026Sheraton Philadelphia Downtown | Philadelphia, PA
Book Now
Menu
Book Now

Josh Schafer
Chief Commercial Officer, Executive Vice President, Business Development at Zevra Therapeutics
Speaker

Agenda Sessions

  • Navigating the First Year – Mastering Post-Launch Execution in Rare Disease

    , 9:45am
    View Session

At this event

Prev
Next
Farrell Simon
Chief Commercial Officer
Trevi Therapeutics, Inc.

See Josh at Rare Disease Conference 2026 - Rare Disease Summit

Book Now